Latest North America News

CLINUVEL Pharmaceuticals has completed recruitment for its Phase III trial of SCENESSE® in vitiligo patients with darker skin types, setting the stage for first results in late 2026. Early clinical observations suggest promising repigmentation outcomes.

Blue Star Helium has successfully drilled the Jackson 2 well to total depth at its Galactica project in Colorado, confirming strong natural gas flow and advancing the project toward commercial production.

Hazer Group has entered a binding six-year strategic alliance with global engineering leader KBR to exclusively market and license its methane pyrolysis technology, targeting the ammonia and methanol sectors. This partnership aims to accelerate commercialisation, expand global reach, and materially de-risk Hazer’s business plan.

Somerset Minerals has completed its acquisition of the high-grade Coppermine copper project in Nunavut, Canada, and is set to begin a maiden exploration campaign backed by a $2.39 million capital raise.

Corporate Travel Management revises down its FY25 revenue outlook by 4%, citing tariff and economic uncertainties in North America and Asia, while strong client wins bolster confidence for FY26.

Yowie Group has clarified misleading substantial shareholder notices linked to Keybridge Capital's administration, denying any current plans for board changes and highlighting ongoing legal disputes.

Amcor has completed its transformative merger with Berry Global ahead of schedule, reporting steady Q3 fiscal 2025 results and setting ambitious synergy targets that promise to reshape its growth trajectory.

Lithium Universe Limited has delivered a robust Definitive Feasibility Study for its Bécancour Lithium Carbonate Refinery, confirming strong economic viability and progressing toward project funding and strategic collaborations.

Green Technology Metals (ASX: GT1) reports a significant lithium resource increase to 30.4 million tonnes and advances key projects in Ontario, while implementing strategic cost controls amid challenging market conditions.

Ava Risk Group reported a solid Q3 FY2025 with $6.5 million in sales orders and a key new contract with Telstra for subsea cable protection, setting the stage for accelerated growth in Q4.

SomnoMed Limited reported a robust 23.2% revenue increase in Q3 FY25, reaffirming its full-year guidance while actively addressing new US tariffs through potential duty-free exemptions.

Hydralyte North America reported a 16% rise in Q1 FY25 net sales and improved gross margins, supported by a strategic capital raise and upcoming product launches targeting brain and gut health.